Michael Trunk

USPTO Granted Patents = 11 (Patent Applications = 9)

CIPO Patents = 8

EPO Patents = 10 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 232(Granted Patents)

Company Filing History:

6 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

3 out of 1,535

Boehringer Ingelheim International Gmbh

patents

1 out of 149

Boehringer Ingelheim Pharma Kg

Years Active: 2004-2015

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9156835 - Micronization method (2015-10-13),

2. 8197845 - Encapsulated tiotropium containing powder formulation for inhalation (2012-06-12),

3. 7763280 - Tiotropium containing powder formulation for inhalation (2010-07-27),

4. 7736628 - Powdered inhalants based on modified lactose mixtures as excipient (2010-06-15),

5. 7658949 - Surface modification of lactose excipient for use in powders for inhalation (2010-02-09),

6. 7642268 - Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament (2010-01-05),

7. 7462367 - Anticholinergic powder formulations for inhalation (2008-12-09),

8. 7309707 - Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament (2007-12-18),

9. 6908928 - Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions (2005-06-21),

10. 6900317 - Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them (2005-05-31),

11. 6777423 - Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions (2004-08-17),

Title: The Innovations of Michael Trunk

Introduction

Michael Trunk is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods and formulations for medication. With a total of 11 patents to his name, Trunk's work has had a substantial impact on the treatment of various respiratory conditions.

Latest Patents

Among his latest patents is a micronization method that produces a virtually anhydrous form of a specific compound, which is crucial for creating effective medicaments with anticholinergic effects. Another significant patent involves an encapsulated tiotropium powder formulation for inhalation, aimed at treating respiratory complaints such as chronic obstructive pulmonary disease (COPD) and asthma. These inventions highlight Trunk's commitment to advancing pharmaceutical technology.

Career Highlights

Throughout his career, Michael Trunk has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Trunk has collaborated with several professionals in his field, including Michael Walz and Hagen Graebner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Michael Trunk's contributions to the pharmaceutical industry through his patents and collaborations demonstrate his dedication to innovation in medicine. His work continues to influence the development of effective treatments for respiratory conditions, showcasing the importance of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.